Vagal atrial fibrillation: What is it and should we treat it?

International Journal of Cardiology

Volumn 201, Issue , 2015, Pages 415-421

  Carpenter, Alexander ^a   Frontera, Antonio ^a   Bond, Richard ^a   Duncan, Edward ^a   Thomas, Glyn ^a  

^a UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Atrial fibrillation in athletes; Autonomic nervous system; Paroxysmal atrial fibrillation; Vagal atrial fibrillation

Indexed keywords

ACETYLCHOLINE; AMIODARONE; ANTIARRHYTHMIC AGENT; DISOPYRAMIDE; FLECAINIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; MUSCARINIC M2 RECEPTOR; POTASSIUM;

ACETYLCHOLINE RELEASE; ARRHYTHMOGENESIS; ATRIAL FIBRILLATION; AUTONOMIC NERVOUS SYSTEM; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; EVENT RELATED POTENTIAL; GANGLION; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HUMAN; MEDICAL DECISION MAKING; PATHOGENESIS; POTASSIUM CURRENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TRAINING; VAGAL ATRIAL FIBRILLATION; VAGUS NERVE STIMULATION; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; TREATMENT OUTCOME; VAGUS NERVE;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; HUMANS; RISK FACTORS; TREATMENT OUTCOME; VAGUS NERVE;

EID: 84943524612     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.08.108     Document Type: Review

References (133)

1. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988 10.1161/01.STR.22.8.983
2. T.J. Wang, M.G. Larson, D. Levy, R.S. Vasan, E.P. Leip, P.A. Wolf, and et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study Circulation 107 2003 2920 2925 10.1161/01.CIR.0000072767.89944.6E
3. A. Ott, M.M.B. Breteler, M.C. de Bruyne, F. van Harskamp, D.E. Grobbee, and A. Hofman Atrial fibrillation and dementia in a population-based study: the Rotterdam Study Stroke 28 1997 316 321 10.1161/01.STR.28.2.316
4. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952 10.1161/01.CIR.98.10.946
5. A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, J.V. Selby, and et al. Prevalence of diagnosed atrial fibrillation in adults Jama 285 2001 2370 10.1001/jama.285.18.2370
6. Y. Miyasaka, M.E. Barnes, B.J. Gersh, S.S. Cha, K.R. Bailey, W.P. Abhayaratna, and et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125 10.1161/CIRCULATIONAHA.105.595140
7. T.N. Nguyen, S.N. Hilmer, and R.G. Cumming Review of epidemiology and management of atrial fibrillation in developing countries Int. J. Cardiol. 167 2013 2412 2420 10.1016/j.ijcard.2013.01.184
8. G.Y.H. Lip, and H.S. Lim Atrial fibrillation and stroke prevention Lancet Neurol. 6 2007 981 993
9. P.A. Wolf, T.R. Dawber, H.E. Thomas, and W.B. Kannel Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study Neurology 28 1978 973 977
10. S. Stewart Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK Heart 90 2004 286 292 10.1136/hrt.2002.008748
11. P.A. Wolf, J.B. Mitchell, C.S. Baker, W.B. Kannel, and R.B. D'Agostino Impact of atrial fibrillation on mortality, stroke, and medical costs Arch. Intern. Med. 158 1998 229 234
12. S. Lévy Classification system of atrial fibrillation Curr. Opin. Cardiol. 15 2000 54 57 10.1097/00001573-200001000-00007
13. V. Fuster, L.E. Rydén, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, and et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Circulation 114 2006 e257 e354 10.1161/CIRCULATIONAHA.106.177292
14. M. Haïssaguerre, P. Jaïs, D.C. Shah, A. Takahashi, M. Hocini, G. Quiniou, and et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins N. Engl. J. Med. 339 1998 659 666 10.1056/NEJM199809033391003
15. C.F. Tsai, C.T. Tai, M.H. Hsieh, W.S. Lin, W.C. Yu, K.C. Ueng, and et al. Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation Circulation 102 2000 67 74
16. W.-S. Lin, C.-T. Tai, M.-H. Hsieh, C.-F. Tsai, Y.-K. Lin, H.-M. Tsao, and et al. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy Circulation 107 2003 3176 3183 10.1161/01.CIR.0000074206.52056.2D
17. D. Katritsis, J.P.A. Ioannidis, E. Giazitzoglou, S. Korovesis, C.E. Anagnostopoulos, and A.J. Camm Conduction delay within the coronary sinus in humans: implications for atrial arrhythmias J. Cardiovasc. Electrophysiol. 13 2002 859 862
18. H. Oral, M. Ozaydin, A. Chugh, C. Scharf, H. Tada, B. Hall, and et al. Role of the coronary sinus in maintenance of atrial fibrillation J. Cardiovasc. Electrophysiol. 14 2003 1329 1336
19. H. Nakagawa, B.J. Scherlag, E. Patterson, A. Ikeda, D. Lockwood, and W.M. Jackman Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation Heart Rhythm. 6 2009 S26 S34 10.1016/j.hrthm.2009.07.029
20. H. Park, M.J. Shen, S. Lin, M.C. Fishbein, L.S. Chen, and P. Chen Neural Mechanisms of Atrial Fibrillation 27 2013 24 28 10.1097/HCO.0b013e32834dc4e8.Neural
21. P.-S. Chen, L.S. Chen, M.C. Fishbein, S.-F. Lin, and S. Nattel Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy Circ. Res. 114 2014 1500 1515 10.1161/CIRCRESAHA.114.303772
22. M. Zimmermann, and D. Kalusche Fluctuation in autonomic tone is a major determinant of sustained atrial arrhythmias in patients with focal ectopy originating from the pulmonary veins J. Cardiovasc. Electrophysiol. 12 2001 285 291
23. M.P. van den Berg, R.J. Hassink, C. Baljé-Volkers, and H.J.G.M. Crijns Role of the autonomic nervous system in vagal atrial fibrillation Heart 89 2003 333 335
24. P.-S. Chen, and A.Y. Tan Autonomic nerve activity and atrial fibrillation Heart Rhythm. 4 2007 S61 S64 10.1016/j.hrthm.2006.12.006
25. E.M. Kanoupakis, E.G. Manios, H.E. Mavrakis, M.D. Kaleboubas, F.I. Parthenakis, and P.E. Vardas Relation of autonomic modulation to recurrence of atrial fibrillation following cardioversion Am. J. Cardiol. 86 2000 954 958
26. P. Coumel Paroxysmal atrial fibrillation: a disorder of autonomic tone? Eur. Heart J. 15 Suppl. A 1994 9 16
27. R.N. Doshi, T.-J. Wu, M. Yashima, Y.-H. Kim, J.J.C. Ong, J.-M. Cao, and et al. Relation between ligament of Marshall and adrenergic atrial tachyarrhythmia Circulation 100 1999 876 883 10.1161/01.CIR.100.8.876
28. C. Dimmer, R. Tavernier, N. Gjorgov, G. Van Nooten, D.L. Clement, and L. Jordaens Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting Am. J. Cardiol. 82 1998 22 25
29. R.J. DiDomenico, and M.G. Massad Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery Ann. Thorac. Surg. 79 2005 728 740 10.1016/j.athoracsur.2004.03.037
30. L. Liu, and S. Nattel Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity Am. J. Physiol. 273 1997 H805 H816
31. J.E. Olgin, H.J. Sih, S. Hanish, J.V. Jayachandran, J. Wu, Q.H. Zheng, and et al. Heterogeneous atrial denervation creates substrate for sustained atrial fibrillation Circulation 98 1998 2608 2614 10.1161/01.CIR.98.23.2608
32. P.B. Lim, L.C. Malcolme-Lawes, T. Stuber, I. Wright, D.P. Francis, D.W. Davies, and et al. Intrinsic cardiac autonomic stimulation induces pulmonary vein ectopy and triggers atrial fibrillation in humans J. Cardiovasc. Electrophysiol. 22 2011 638 646 10.1111/j.1540-8167.2010.01992.x
33. P. Coumel, P. Attuel, J. Lavallée, D. Flammang, J.F. Leclercq, and R. Slama The atrial arrhythmia syndrome of vagal origin Arch. Mal. Coeur Vaiss. 71 1978 645 656
34. L. Liu, and S. Nattel Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity Am. J. Physiol. Heart Circ. Physiol. 273 1997 H805 H816
35. S. Sato, S. Yamauchi, R.B. Schuessler, J.P. Boineau, Y. Matsunaga, and J.L. Cox The effect of augmented atrial hypothermia on atrial refractory period, conduction, and atrial flutter/fibrillation in the canine heart J. Thorac. Cardiovasc. Surg. 104 1992 297 306
36. Z. Wang, J. Feng, and S. Nattel Idiopathic atrial fibrillation in dogs: electrophysiologic determinants and mechanisms of antiarrhythmic action of flecainide J. Am. Coll. 26 1995
37. J. Wang, L. Liu, J. Feng, and S. Nattel Regional and functional factors determining induction and maintenance of atrial fibrillation in dogs Am. J. Physiol. 271 1996 H148 H158
38. D. Dobrev, E. Graf, E. Wettwer, H.M. Himmel, O. Hala, C. Doerfel, and et al. Molecular basis of downregulation of G-protein-coupled inward rectifying K + current (IK, ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced IK, ACh and muscarinic receptor-mediated shortening of action potentials Circulation 104 2001 2551 2557 10.1161/hc4601.099466
39. M.S. Spach, J.F. Heidlage, P.C. Dolber, and R.C. Barr Electrophysiological effects of remodeling cardiac gap junctions and cell size: experimental and model studies of normal cardiac growth Circ. Res. 86 2000 302 311 10.1161/01.RES.86.3.302
40. E.J. Vigmond, V. Tsoi, S. Kuo, H. Arevalo, J. Kneller, S. Nattel, and et al. The effect of vagally induced dispersion of action potential duration on atrial arrhythmogenesis Heart Rhythm. 1 2004 334 344 10.1016/j.hrthm.2004.03.077
41. F. Sarmast, A. Kolli, A. Zaitsev, K. Parisian, A.S. Dhamoon, P.K. Guha, and et al. Cholinergic atrial fibrillation: I(K, ACh) gradients determine unequal left/right atrial frequencies and rotor dynamics Cardiovasc. Res. 59 2003 863 873
42. J. Kneller Cholinergic atrial fibrillation in a computer model of a two-dimensional sheet of canine atrial cells with realistic ionic properties Circ. Res. 90 2002 73e 87e 10.1161/01.RES.0000019783.88094.BA
43. M. Mandyam, and V. Vedantham Alcohol and vagal tone as triggers for paroxysmal atrial fibrillation Am. J. Cardiol. 110 2012 364 368 10.1016/j.amjcard.2012.03.033.Alcohol
44. D. Nemirovsky, R. Hutter, and J.A. Gomes The electrical substrate of vagal atrial fibrillation as assessed by the signal-averaged electrocardiogram of the P wave Pacing Clin. Electrophysiol. 31 2008 308 313 10.1111/j.1540-8159.2008.00990.x
45. Y. Yeh, K. Lemola, and S. Nattel Vagal atrial fibrillation Acta Cardiol. Sin. 2007 1 12
46. K. Lemola, D. Chartier, Y.-H. Yeh, M. Dubuc, R. Cartier, A. Armour, and et al. Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia Circulation 117 2008 470 477 10.1161/CIRCULATIONAHA.107.737023
47. A. Capucci, G. Coccagna, A. Santarelli, S. Bauleo, and G. Boriani Prevalence of the sympathetic influence before atrial fibrillation onset in the so-called "vagal paroxysmal atrial fibrillation patients" J. Am. Coll. Cardiol. 31 1998 184 10.1016/S0735-1097(98)81439-3
48. A. Hansson, B. Madsen-Härdig, and S.B. Olsson Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: a study based on interviews with 100 patients seeking hospital assistance BMC Cardiovasc. Disord. 4 2004 13 10.1186/1471-2261-4-13
49. C.B. de Vos, R. Nieuwlaat, H.J.G.M. Crijns, A.J. Camm, J.-Y. LeHeuzey, C.J. Kirchhof, and et al. Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey Eur. Heart J. 29 2008 632 639 10.1093/eurheartj/ehn025
50. S.K. Goyal, and A. Sharma Atrial fibrillation in obstructive sleep apnea World J. Cardiol. 5 2013 157 163 10.4330/wjc.v5.i6.157
51. A.S. Gami, G. Pressman, S.M. Caples, R. Kanagala, J.J. Gard, D.E. Davison, and et al. Association of atrial fibrillation and obstructive sleep apnea Circulation 110 2004 364 367 10.1161/01.CIR.0000136587.68725.8E
52. S.J. Asirvatham, and S. Kapa Sleep apnea and atrial fibrillation: the autonomic link J. Am. Coll. Cardiol. 54 2009 2084 2086 10.1016/j.jacc.2009.09.017
53. A.S. Gami, S.M. Caples, and V.K. Somers Obesity and obstructive sleep apnea Endocrinol. Metab. Clin. North Am. 32 2003 869 894
54. R. Wolk, T. Kara, and V.K. Somers Sleep-disordered breathing and cardiovascular disease Circulation 108 2003 9 12 10.1161/01.CIR.0000072346.56728.E4
55. Y.M. Reddy, D. Singh, D. Nagarajan, J. Pillarisetti, M. Biria, H. Boolani, and et al. Atrial fibrillation ablation in patients with gastroesophageal reflux disease or irritable bowel syndrome - the heart to gut connection! J. Interv. Card. Electrophysiol. 37 2013 259 265 10.1007/s10840-013-9807-5
56. D.R. Swanson Running, esophageal acid reflux, and atrial fibrillation: a chain of events linked by evidence from separate medical literatures Med. Hypotheses 71 2008 178 185 10.1016/j.mehy.2008.02.017
57. N. Fragakis, G. Vicedomini, and C. Pappone Endurance Sport Activity and Risk of Atrial Fibrillation - Epidemiology, Proposed Mechanisms and Management 3 2014
58. L. Mont, A. Sambola, J. Brugada, M. Vacca, J. Marrugat, R. Elosua, and et al. Long-lasting sport practice and lone atrial fibrillation Eur. Heart J. 23 2002 477 482 10.1053/euhj.2001.2802
59. L. Molina, L. Mont, J. Marrugat, A. Berruezo, J. Brugada, J. Bruguera, and et al. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study Europace 10 2008 618 623 10.1093/europace/eun071
60. H. Heidbüchel, W. Anné, R. Willems, B. Adriaenssens, F. Van de Werf, and H. Ector Endurance sports is a risk factor for atrial fibrillation after ablation for atrial flutter Int. J. Cardiol. 107 2006 67 72 10.1016/j.ijcard.2005.02.043
61. R. Elosua, A. Arquer, L. Mont, A. Sambola, L. Molina, E. García-Morán, and et al. Sport practice and the risk of lone atrial fibrillation: a case-control study Int. J. Cardiol. 108 2006 332 337 10.1016/j.ijcard.2005.05.020
62. J. Karjalainen, U.M. Kujala, J. Kaprio, S. Sarna, and M. Viitasalo Lone atrial fibrillation in vigorously exercising middle aged men: case-control study BMJ 316 1998 1784 1785
63. J. Abdulla, and J.R. Nielsen Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis Europace 11 2009 1156 1159 10.1093/europace/eup197
64. L. Mont, D. Tamborero, R. Elosua, I. Molina, B. Coll-Vinent, M. Sitges, and et al. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals Europace 10 2008 15 20 10.1093/europace/eum263
65. A. Aizer, J.M. Gaziano, N.R. Cook, J.E. Manson, J.E. Buring, and C.M. Albert Relation of vigorous exercise to risk of atrial fibrillation Am. J. Cardiol. 103 2009 1572 1577 10.1016/j.amjcard.2009.01.374
66. D.P. Zipes, M.J. Ackerman, N.A.M. Estes, A.O. Grant, R.J. Myerburg, and G. Van Hare Task force 7: arrhythmias J. Am. Coll. Cardiol. 45 2005 1354 1363 10.1016/j.jacc.2005.02.014
67. F. Furlanello, A. Bertoldi, M. Dallago, A. Galassi, F. Fernando, A. Biffi, and et al. Atrial fibrillation in elite athletes J. Cardiovasc. Electrophysiol. 9 1998 S63 S68
68. H. Heidbüchel, N. Panhuyzen-Goedkoop, D. Corrado, E. Hoffmann, A. Biffi, P. Delise, and et al. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions part I: supraventricular arrhythmias and pacemakers Eur. J. Cardiovasc. Prev. Rehabil. 13 2006 475 484 10.1097/01.hjr.0000216543.54066.72
69. F. Furlanello, P. Lupo, M. Pittalis, S. Foresti, L. Vitali-Serdoz, P. Francia, and et al. Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition J. Cardiovasc. Electrophysiol. 19 2008 457 462 10.1111/j.1540-8167.2007.01077.x
70. O.F. Sharifov, V.V. Fedorov, G.G. Beloshapko, A.V. Glukhov, A.V. Yushmanova, and L.V. Rosenshtraukh Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs J. Am. Coll. Cardiol. 43 2004 483 490 10.1016/j.jacc.2003.09.030
71. J.D. Mills, G.E. Moore, and P.D. Thompson The athlete's heart Clin. Sports Med. 16 1997 725 737 10.1016/S0278-5919(05)70050-8
72. M. Wilhelm, L. Roten, H. Tanner, I. Wilhelm, J.-P. Schmid, and H. Saner Atrial remodeling, autonomic tone, and lifetime training hours in nonelite athletes Am. J. Cardiol. 108 2011 580 585 10.1016/j.amjcard.2011.03.086
73. E. Guasch, B. Benito, X. Qi, C. Cifelli, P. Naud, Y. Shi, and et al. Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model J. Am. Coll. Cardiol. 62 2013 68 77 10.1016/j.jacc.2013.01.091
74. C. Kasapis, and P.D. Thompson The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review J. Am. Coll. Cardiol. 45 2005 1563 1569 10.1016/j.jacc.2004.12.077
75. D.R. Swanson Atrial fibrillation in athletes: implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism Med. Hypotheses 66 2006 1085 1092 10.1016/j.mehy.2006.01.006
76. M.M. Lindsay, and F.G. Dunn Biochemical evidence of myocardial fibrosis in veteran endurance athletes Br. J. Sports Med. 41 2007 447 452 10.1136/bjsm.2006.031534
77. B. Benito, G. Gay-Jordi, A. Serrano-Mollar, E. Guasch, Y. Shi, J.-C. Tardif, and et al. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training Circulation 123 2011 13 22 10.1161/CIRCULATIONAHA.110.938282
78. A. Pelliccia, B.J. Maron, F.M. Di Paolo, A. Biffi, F.M. Quattrini, C. Pisicchio, and et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes J. Am. Coll. Cardiol. 46 2005 690 696 10.1016/j.jacc.2005.04.052
79. F. Ravelli, and M. Allessie Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart Circulation 96 1997 1686 1695
80. S. Baldesberger, U. Bauersfeld, R. Candinas, B. Seifert, M. Zuber, M. Ritter, and et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists Eur. Heart J. 29 2008 71 78 10.1093/eurheartj/ehm555
81. A. D'Souza, A. Bucchi, A.B. Johnsen, S.J.R.J. Logantha, O. Monfredi, J. Yanni, and et al. Exercise training reduces resting heart rate via downregulation of the funny channel HCN4 Nat. Commun. 5 2014 3775 10.1038/ncomms4775
82. H.S. Abed, G.A. Wittert, D.P. Leong, M.G. Shirazi, B. Bahrami, M.E. Middeldorp, and et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial JAMA 310 2013 2050 2060 10.1001/jama.2013.280521
83. R.K. Pathak, M.E. Middeldorp, D.H. Lau, A.B. Mehta, R. Mahajan, D. Twomey, and et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation J. Am. Coll. Cardiol. 64 2014 2222 2231 10.1016/j.jacc.2014.09.028
84. R. Rosso, P.B. Sparks, J.B. Morton, P.M. Kistler, J.K. Vohra, K. Halloran, and et al. Vagal paroxysmal atrial fibrillation: prevalence and ablation outcome in patients without structural heart disease J. Cardiovasc. Electrophysiol. 21 2010 489 493 10.1111/j.1540-8167.2009.01658.x
85. R.G. Hart, L.A. Pearce, R.M. Rothbart, J.H. McAnulty, R.W. Asinger, and J.L. Halperin Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy J. Am. Coll. Cardiol. 35 2000 183 187 10.1016/S0735-1097(99)00489-1
86. M.M. Bersohn, A.L. Waldo, and J.L. Halperin Subclinical atrial fibrillation and the risk of stroke N. Engl. J. Med. 366 2012 1352 (author reply 1352-3. http://dx.doi.org/10.1056/NEJMc1201844#SA5)
87. L. Elijovich, S.A. Josephson, G.L. Fung, and W.S. Smith Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors J. Stroke Cerebrovasc. Dis. 18 2009 185 189 10.1016/j.jstrokecerebrovasdis.2008.09.005
88. S.H. Hohnloser, D. Pajitnev, J. Pogue, J.S. Healey, M.A. Pfeffer, S. Yusuf, and et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W sub-study J. Am. Coll. Cardiol. 50 2007 2156 2161 10.1016/j.jacc.2007.07.076
89. R.R. Tilz, A. Rillig, A.-M. Thum, A. Arya, P. Wohlmuth, A. Metzner, and et al. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy J. Am. Coll. Cardiol. 60 2012 1921 1929 10.1016/j.jacc.2012.04.060
90. T. Kato, T. Yamashita, K. Sagara, H. Iinuma, and L. Fu Progressive Nature of Paroxysmal Atrial Fibrillation 68 2004 568 572
91. M.C.E.F. Wijffels, C.J.H.J. Kirchhof, R. Dorland, and M.A. Allessie Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats Circulation 92 1995 1954 1968 10.1161/01.CIR.92.7.1954
92. D. Li, S. Fareh, T.K. Leung, and S. Nattel Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort Circulation 100 1999 87 95
93. Y. Iwasaki, K. Nishida, T. Kato, and S. Nattel Atrial fibrillation pathophysiology: implications for management Circulation 124 2011 2264 2274 10.1161/CIRCULATIONAHA.111.019893
94. F.G. Cosio, E. Aliot, G.L. Botto, H. Heidbüchel, C.J. Geller, P. Kirchhof, and et al. Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode Europace 10 2008 21 27 10.1093/europace/eum276
95. W. Anné, R. Willems, P. Holemans, F. Beckers, T. Roskams, I. Lenaerts, and et al. Self-terminating AF depends on electrical remodeling while persistent AF depends on additional structural changes in a rapid atrially paced sheep model J. Mol. Cell. Cardiol. 43 2007 148 158 10.1016/j.yjmcc.2007.05.010
96. B. Burstein, and S. Nattel Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation J. Am. Coll. Cardiol. 51 2008 802 809 10.1016/j.jacc.2007.09.064
97. X.Y. Qi, Y.-H. Yeh, L. Xiao, B. Burstein, A. Maguy, D. Chartier, and et al. Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current Circ. Res. 103 2008 845 854 10.1161/CIRCRESAHA.108.175463
98. L. Yue, P. Melnyk, R. Gaspo, Z. Wang, and S. Nattel Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation Circ. Res. 84 1999 776 784
99. R.F. Bosch, C.R. Scherer, N. Rüb, S. Wöhrl, K. Steinmeyer, H. Haase, and et al. Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces I(Ca, L) and I(to) in rapid atrial pacing in rabbits J. Am. Coll. Cardiol. 41 2003 858 869
100. Z. Lu, B. Scherlag, J. Lin, and G. Niu Atrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing Circulation 1 2008 184 192 10.1161/CIRCEP.108.784272.Atrial
101. G.Y.H. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J.G.M. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2010 263 272 10.1378/chest.09-1584
102. S. Nattel, E. Guasch, I. Savelieva, F.G. Cosio, I. Valverde, J.L. Halperin, and et al. Early management of atrial fibrillation to prevent cardiovascular complications Eur. Heart J. 2014 10.1093/eurheartj/ehu028
103. A.J. Camm, G. Breithardt, H. Crijns, P. Dorian, P. Kowey, J.-Y. Le Heuzey, and et al. Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation) J. Am. Coll. Cardiol. 58 2011 493 501 10.1016/j.jacc.2011.03.034
104. C.B. De Vos, G. Breithardt, A.J. Camm, P. Dorian, P.R. Kowey, J.-Y. Le Heuzey, and et al. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of atrial fibrillation cohort: clinical correlates and the effect of rhythm-control therapy Am. Heart J. 163 2012 887 893 10.1016/j.ahj.2012.02.015
105. I.C. Van Gelder, V.E. Hagens, H.A. Bosker, J.H. Kingma, O. Kamp, T. Kingma, and et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N. Engl. J. Med. 347 2002 1834 1840 10.1056/NEJMoa021375
106. J. Carlsson, S. Miketic, J. Windeler, A. Cuneo, S. Haun, S. Micus, and et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study J. Am. Coll. Cardiol. 41 2003 1690 1696
107. S.H. Hohnloser, K.H. Kuck, and J. Lilienthal Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial Lancet 356 2000 1789 1794
108. D.G. Wyse, A.L. Waldo, J.P. DiMarco, M.J. Domanski, Y. Rosenberg, E.B. Schron, and et al. A comparison of rate control and rhythm control in patients with atrial fibrillation N. Engl. J. Med. 347 2002 1825 1833 10.1056/NEJMoa021328
109. B. Olshansky, L.E. Rosenfeld, A.L. Warner, A.J. Solomon, G. O'Neill, A. Sharma, and et al. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation J. Am. Coll. Cardiol. 43 2004 1201 1208 10.1016/j.jacc.2003.11.032
110. S. Ogawa, T. Yamashita, T. Yamazaki, Y. Aizawa, H. Atarashi, H. Inoue, and et al. Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study Circ. J. 73 2009 242 248
111. C.T. January, L.S. Wann, J.S. Alpert, H. Calkins, J.C. Cleveland, J.E. Cigarroa, and et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J. Am. Coll. Cardiol. 64 2014 e1 e76 10.1016/j.jacc.2014.03.022
112. V. Fuster, L.E. Rydén, D.S. Cannom, H.J. Crijns, A.B. Curtis, A. Kenneth, and et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation - Executive Summary 2006 10.1161/CIRCULATIONAHA.106.177031
113. S.S. Andersen, M.L. Hansen, G.H. Gislason, T.K. Schramm, F. Folke, E. Fosbøl, and et al. Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study Europace 11 2009 886 891 10.1093/europace/eup119
114. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction N. Engl. J. Med. 321 1989 406 412 10.1056/NEJM198908103210629
115. J. Rawlins, A. Bhan, and S. Sharma Left ventricular hypertrophy in athletes Eur. J. Echocardiogr. 10 2009 350 356 10.1093/ejechocard/jep017
116. P. Schauerte, B.J. Scherlag, J. Pitha, M.A. Scherlag, D. Reynolds, R. Lazzara, and et al. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation Circulation 102 2000 2774 2780
117. J.L. Báez-Escudero, T. Keida, A.S. Dave, K. Okishige, and M. Valderrábano Ethanol infusion in the vein of Marshall leads to parasympathetic denervation of the human left atrium: implications for atrial fibrillation J. Am. Coll. Cardiol. 63 2014 1892 1901 10.1016/j.jacc.2014.01.032
118. R. Lemery, D. Birnie, and A.S.L. Tang Significant vagal denervation occurs in patients undergoing LA circumferential catheter ablation of atrial fibrillation Heart Rhythm. 2 2005 S28 10.1016/j.hrthm.2005.02.097
119. C. Pappone, V. Santinelli, F. Manguso, G. Vicedomini, F. Gugliotta, G. Augello, and et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation Circulation 109 2004 327 334 10.1161/01.CIR.0000112641.16340.C7
120. A. Bauer, I. Deisenhofer, R. Schneider, B. Zrenner, P. Barthel, M. Karch, and et al. Effects of circumferential or segmental pulmonary vein ablation for paroxysmal atrial fibrillation on cardiac autonomic function Heart Rhythm. 3 2006 1428 1435 10.1016/j.hrthm.2006.08.025
121. J.E. Cummings, I. Gill, R. Akhrass, M. Dery, L.A. Biblo, and K.J. Quan Preservation of the anterior fat pad paradoxically decreases the incidence of postoperative atrial fibrillation in humans J. Am. Coll. Cardiol. 43 2004 994 1000 10.1016/j.jacc.2003.07.055
122. R. Lemery, D. Birnie, A.S.L. Tang, M. Green, and M. Gollob Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation Heart Rhythm. 3 2006 387 396 10.1016/j.hrthm.2006.01.009
123. M. Hirose, Z. Leatmanoratn, K.R. Laurita, and M.D. Carlson Partial vagal denervation increases vulnerability to vagally induced atrial fibrillation J. Cardiovasc. Electrophysiol. 13 2002 1272 1279
124. E. Mikhaylov, A. Kanidieva, N. Sviridova, M. Abramov, S. Gureev, T. Szili-Torok, and et al. Outcome of anatomic ganglionated plexi ablation to treat paroxysmal atrial fibrillation: a 3-year follow-up study Europace 13 2011 362 370 10.1093/europace/euq416
125. E. Pokushalov, B. Kozlov, A. Romanov, A. Strelnikov, S. Bayramova, D. Sergeevichev, and et al. Botulinum toxin injection in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery: results of a randomized pilot study J. Am. Coll. Cardiol. 64 2014 628 629 10.1016/j.jacc.2014.04.062
126. S. Sakamoto, R.B. Schuessler, A.M. Lee, A. Aziz, S.C. Lall, and R.J. Damiano Vagal denervation and reinnervation after ablation of ganglionated plexi J. Thorac. Cardiovasc. Surg. 139 2010 444 452 10.1016/j.jtcvs.2009.04.056
127. H.G. Je, D.J. Shuman, and N. Ad A systematic review of minimally invasive surgical treatment for atrial fibrillation: a comparison of the Cox-Maze procedure, beating-heart epicardial ablation, and the hybrid procedure on safety and efficacy † Eur. J. Cardiothorac. Surg. 2015 ezu536 10.1093/ejcts/ezu536
128. D.G. Wyse A critical perspective on the role of catheter ablation in management of atrial fibrillation Can. J. Cardiol. 29 2013 1150 1157 10.1016/j.cjca.2013.03.001
129. C. Pappone, S. Rosanio, G. Augello, G. Gallus, G. Vicedomini, P. Mazzone, and et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study J. Am. Coll. Cardiol. 42 2003 185 197
130. T.J. Bunch, B.G. Crandall, J.P. Weiss, H.T. May, T.L. Bair, J.S. Osborn, and et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation J. Cardiovasc. Electrophysiol. 22 2011 839 845 10.1111/j.1540-8167.2011.02035.x
131. R.J. Hunter, J. McCready, I. Diab, S.P. Page, M. Finlay, L. Richmond, and et al. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death Heart 98 2012 48 53 10.1136/heartjnl-2011-300720
132. A. Cheema, C.R. Vasamreddy, D. Dalal, J.E. Marine, J. Dong, C.A. Henrikson, and et al. Long-term single procedure efficacy of catheter ablation of atrial fibrillation J. Interv. Card. Electrophysiol. 15 2006 145 155 10.1007/s10840-006-9005-9
133. H. Calkins, M.R. Reynolds, P. Spector, M. Sondhi, Y. Xu, A. Martin, and et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses Circ. Arrhythm. Electrophysiol. 2 2009 349 361 10.1161/CIRCEP.108.824789